BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Havens JR, Lofwall MR, Frost SD, Oser CB, Leukefeld CG, Crosby RA. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health. 2013;103:e44-e52. [PMID: 23153148 DOI: 10.2105/ajph.2012.300874] [Cited by in Crossref: 103] [Cited by in F6Publishing: 82] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Mateu-Gelabert P, Guarino H. The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids. Int J Drug Policy 2018;57:130-2. [PMID: 29627198 DOI: 10.1016/j.drugpo.2018.03.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Watson DP, Swartz JA, Robison-Taylor L, Mackesy-Amiti ME, Erwin K, Gastala N, Jimenez AD, Staton MD, Messmer S. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial. BMC Public Health 2021;21:630. [PMID: 33789642 DOI: 10.1186/s12889-021-10669-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Knudsen HK, Lofwall MR, Walsh SL, Havens JR. Impact of health reform on health insurance status among persons who use opioids in eastern Kentucky: A prospective cohort analysis. Int J Drug Policy 2019;70:8-14. [PMID: 31054372 DOI: 10.1016/j.drugpo.2019.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Young AM, Rudolph AE, Havens JR. Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned. Curr HIV/AIDS Rep 2018;15:113-9. [PMID: 29457200 DOI: 10.1007/s11904-018-0391-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
5 Lake S, Milloy MJ, Dong H, Hayashi K, Wood E, Kerr T, DeBeck K. Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs. Drug Alcohol Depend 2016;169:73-9. [PMID: 27780105 DOI: 10.1016/j.drugalcdep.2016.10.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
6 Lier AJ, Smith K, Odekon K, Bronson S, Taub E, Tharakan M, Kelly GJ, Patel P, Marcos LA. Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users. Infect Dis Ther 2019;8:417-28. [PMID: 31129777 DOI: 10.1007/s40121-019-0249-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Oser CB, Harp KL. Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance. J Subst Abuse Treat 2015;48:77-84. [PMID: 25200740 DOI: 10.1016/j.jsat.2014.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
8 Schalkoff CA, Lancaster KE, Gaynes BN, Wang V, Pence BW, Miller WC, Go VF. The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases. Subst Abus 2020;41:35-69. [PMID: 31403903 DOI: 10.1080/08897077.2019.1635555] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Turner-Bicknell T. Implementing best-practice with a local syringe service program: Needs-based syringe distribution. Public Health Nurs 2021;38:85-92. [PMID: 33084122 DOI: 10.1111/phn.12823] [Reference Citation Analysis]
10 Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, Thornton K, Bisztray B, Fiuty P, Page K. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug Alcohol Depend 2021;220:108527. [PMID: 33465605 DOI: 10.1016/j.drugalcdep.2021.108527] [Reference Citation Analysis]
11 Samoff E, Mobley V, Hudgins M, Cope AB, Adams ND, Caputo CR, Dennis AM, Billock RM, Crowley CA, Clymore JM, Foust E. HIV Outbreak Control With Effective Access to Care and Harm Reduction in North Carolina, 2017-2018. Am J Public Health 2020;110:394-400. [PMID: 31944835 DOI: 10.2105/AJPH.2019.305490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
12 Boodram B, Hotton AL, Shekhtman L, Gutfraind A, Dahari H. High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members. J Urban Health 2018;95:71-82. [PMID: 28875410 DOI: 10.1007/s11524-017-0185-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
13 Davis SM, Davidov D, Kristjansson AL, Zullig K, Baus A, Fisher M. Qualitative case study of needle exchange programs in the Central Appalachian region of the United States. PLoS One 2018;13:e0205466. [PMID: 30312333 DOI: 10.1371/journal.pone.0205466] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Zibbell JE, Hart-Malloy R, Barry J, Fan L, Flanigan C. Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health 2014;104:2226-32. [PMID: 25211717 DOI: 10.2105/AJPH.2014.302142] [Cited by in Crossref: 71] [Cited by in F6Publishing: 48] [Article Influence: 8.9] [Reference Citation Analysis]
15 Moorman JP, Krolikowski MR, Mathis SM, Pack RP. HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia. Curr HIV/AIDS Rep 2018;15:308-14. [PMID: 29931466 DOI: 10.1007/s11904-018-0404-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis. 2014;14:17. [PMID: 24405790 DOI: 10.1186/1471-2334-14-17] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
17 Stephens DB, Young AM, Havens JR. Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs. Int J Drug Policy 2017;47:86-94. [PMID: 28648353 DOI: 10.1016/j.drugpo.2017.05.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
18 Webster JM, Dickson MF, Mannan F, Staton M. Characteristics of Prescription-Opioid-Impaired and Other Substance-Impaired Drivers in Rural Appalachian Kentucky. J Psychoactive Drugs 2018;50:373-81. [PMID: 30204565 DOI: 10.1080/02791072.2018.1514477] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Bruno T, Pharr JR. Retrospective case series analysis of characteristics and trends in unintentional pharmaceutical drug poisoning by methadone, opioid analgesics, antidepressants and benzodiazepines in Clark County, NV 2009-13. J Public Health (Oxf) 2017;39:304-11. [PMID: 27222239 DOI: 10.1093/pubmed/fdw052] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Syvertsen JL, Paquette CE, Pollini RA. Down in the valley: Trajectories of injection initiation among young injectors in California's Central Valley. Int J Drug Policy 2017;44:41-9. [PMID: 28458170 DOI: 10.1016/j.drugpo.2017.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
21 Mateu-Gelabert P, Guarino H, Zibbell JE, Teubl J, Fong C, Goodbody E, Edlin B, Salvati C, Friedman SR. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Harm Reduct J 2020;17:22. [PMID: 32228700 DOI: 10.1186/s12954-020-00367-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Lankenau SE, Kecojevic A, Silva K. Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. Drugs (Abingdon Engl) 2015;22:35-42. [PMID: 25598589 DOI: 10.3109/09687637.2014.970515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
23 Davis SM, Daily S, Kristjansson AL, Kelley GA, Zullig K, Baus A, Davidov D, Fisher M. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis. Harm Reduct J. 2017;14:25. [PMID: 28514954 DOI: 10.1186/s12954-017-0156-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
24 Marks KR, Leukefeld CG, Dennis ML, Scott CK, Funk R; JJ-TRIALS Cooperative. Geographic differences in substance use screening for justice-involved youth. J Subst Abuse Treat 2019;102:40-6. [PMID: 31202287 DOI: 10.1016/j.jsat.2019.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dunn KE, Saulsgiver KA, Patrick ME, Heil SH, Higgins ST, Sigmon SC. Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers. Drug Alcohol Depend 2013;133:625-32. [PMID: 24051063 DOI: 10.1016/j.drugalcdep.2013.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
26 Frimpong JA, D'Aunno T, Perlman DC, Strauss SM, Mallow A, Hernandez D, Schackman BR, Feaster DJ, Metsch LR. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial. Trials 2016;17:117. [PMID: 26936623 DOI: 10.1186/s13063-016-1225-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Sacamano PL, Mehta SH, Latkin C, Falade-Nwulia O, Kirk GD, Rudolph AE. Characterizing latent classes of social support among persons who inject drugs. Drug Alcohol Depend 2020;207:107816. [PMID: 31923777 DOI: 10.1016/j.drugalcdep.2019.107816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Kim YM. Comparing Medical Comorbidities Between Opioid and Cocaine Users: A Data Mining Approach. Addict Health 2019;11:223-33. [PMID: 32206215 DOI: 10.22122/ahj.v11i4.242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Mokhtari M, Basirkazeruni H, Rostami M. The Correlation between Different Risk Factors of Hepatitis C and Different Genotypes. Adv Biomed Res 2017;6:45. [PMID: 28503500 DOI: 10.4103/2277-9175.204588] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Ondocsin J, Mars SG, Howe M, Ciccarone D. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency. Harm Reduct J 2020;17:74. [PMID: 33046092 DOI: 10.1186/s12954-020-00416-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Stephens DB, Havens JR. Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status. J Stud Alcohol Drugs 2013;74:386-95. [PMID: 23490567 DOI: 10.15288/jsad.2013.74.386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
32 Havens JR, Walsh SL, Korthuis PT, Fiellin DA. Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment. Curr HIV/AIDS Rep 2018;15:315-23. [PMID: 29948609 DOI: 10.1007/s11904-018-0402-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
33 Paquette CE, Pollini RA. Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug Alcohol Depend 2018;188:239-50. [PMID: 29787966 DOI: 10.1016/j.drugalcdep.2018.03.049] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
34 Young AM, Halgin DS, Havens JR. Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination. AIDS Care 2015;27:1000-4. [PMID: 25730519 DOI: 10.1080/09540121.2015.1017443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Young AM, Halgin DS, DiClemente RJ, Sterk CE, Havens JR. Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensation. PLoS One 2014;9:e101047. [PMID: 24992659 DOI: 10.1371/journal.pone.0101047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Quintero GC. Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol 2017;9:13-21. [PMID: 28223849 DOI: 10.2147/JEP.S124391] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
37 Stephens DB, Young AM, Mullins UL, Havens JR. Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users. J Med Virol 2016;88:512-20. [PMID: 26288383 DOI: 10.1002/jmv.24358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kapadia F, Siconolfi DE, Barton S, Olivieri B, Lombardo L, Halkitis PN. Social support network characteristics and sexual risk taking among a racially/ethnically diverse sample of young, urban men who have sex with men. AIDS Behav 2013;17:1819-28. [PMID: 23553346 DOI: 10.1007/s10461-013-0468-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
39 Davis SM, Kristjansson AL, Davidov D, Zullig K, Baus A, Fisher M. Barriers to using new needles encountered by rural Appalachian people who inject drugs: implications for needle exchange. Harm Reduct J 2019;16:23. [PMID: 30940136 DOI: 10.1186/s12954-019-0295-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
40 Staton M, Ciciurkaite G, Havens J, Tillson M, Leukefeld C, Webster M, Oser C, Peteet B. Correlates of Injection Drug Use Among Rural Appalachian Women. J Rural Health 2018;34:31-41. [PMID: 28685884 DOI: 10.1111/jrh.12256] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
41 Rudolph AE, Young AM, Havens JR. Examining the Social Context of Injection Drug Use: Social Proximity to Persons Who Inject Drugs Versus Geographic Proximity to Persons Who Inject Drugs. Am J Epidemiol 2017;186:970-8. [PMID: 28535162 DOI: 10.1093/aje/kwx162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
42 Smith RV, Young AM, Mullins UL, Havens JR. Individual and Network Correlates of Antisocial Personality Disorder Among Rural Nonmedical Prescription Opioid Users. J Rural Health 2017;33:198-207. [PMID: 27171488 DOI: 10.1111/jrh.12184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health 2014;68:792-8. [PMID: 24692631 DOI: 10.1136/jech-2014-203935] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
44 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
45 Longmire AG, Sims S, Rytsareva I, Campo DS, Skums P, Dimitrova Z, Ramachandran S, Medrzycki M, Thai H, Ganova-Raeva L, Lin Y, Punkova LT, Sue A, Mirabito M, Wang S, Tracy R, Bolet V, Sukalac T, Lynberg C, Khudyakov Y. GHOST: global hepatitis outbreak and surveillance technology. BMC Genomics 2017;18:916. [PMID: 29244005 DOI: 10.1186/s12864-017-4268-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
46 Liu Y, Zou X, Chen W, Gong C, Ling L. Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study. Int J Environ Res Public Health 2019;16:E4436. [PMID: 31726750 DOI: 10.3390/ijerph16224436] [Reference Citation Analysis]
47 Frimpong JA, D'Aunno T, Jiang L. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study. Am J Public Health 2014;104:e75-82. [PMID: 24825236 DOI: 10.2105/AJPH.2013.301827] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
48 Jost JJ, Tempalski B, Vera T, Akiyama MJ, Mangalonzo AP, Litwin AH. Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs. Int J Environ Res Public Health. 2019;16:1958. [PMID: 31159479 DOI: 10.3390/ijerph16111958] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
49 Surratt HL, Otachi JK, Mclouth CJ, Vundi N. Healthcare stigma and HIV risk among rural people who inject drugs. Drug and Alcohol Dependence 2021;226:108878. [DOI: 10.1016/j.drugalcdep.2021.108878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Cheng T, Small W, Dong H, Nosova E, Hayashi K, DeBeck K. An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy 2018;13:41. [PMID: 30482215 DOI: 10.1186/s13011-018-0180-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
51 Staton-Tindall M, Webster JM, Oser CB, Havens JR, Leukefeld CG. Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women. Soc Work Public Health. 2015;30:385-396. [PMID: 25950907 DOI: 10.1080/19371918.2015.1021024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
52 Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The Past, Present, and Future of PrEP implementation Among People Who Use Drugs. Curr HIV/AIDS Rep 2021;18:328-38. [PMID: 33907971 DOI: 10.1007/s11904-021-00556-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Malekinejad M, Horvath H, Snyder H, Brindis CD. The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders. Health Res Policy Syst 2018;16:81. [PMID: 30115085 DOI: 10.1186/s12961-018-0336-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Young AM, DiClemente RJ, Halgin DS, Sterk CE, Havens JR. HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study. BMC Public Health 2014;14:537. [PMID: 24885970 DOI: 10.1186/1471-2458-14-537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
55 Fraser H, Zibbell J, Hoerger T, Hariri S, Vellozzi C, Martin NK, Kral AH, Hickman M, Ward JW, Vickerman P. Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction. 2018;113:173-182. [PMID: 28734093 DOI: 10.1111/add.13948] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
56 Grau LE, Zhan W, Heimer R. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut. Drug Alcohol Rev 2016;35:628-36. [PMID: 27073014 DOI: 10.1111/dar.12396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend 2019;200:95-114. [PMID: 31121495 DOI: 10.1016/j.drugalcdep.2019.02.033] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 25.7] [Reference Citation Analysis]
58 Ramachandran S, Thai H, Forbi JC, Galang RR, Dimitrova Z, Xia GL, Lin Y, Punkova LT, Pontones PR, Gentry J, Blosser SJ, Lovchik J, Switzer WM, Teshale E, Peters P, Ward J, Khudyakov Y; Hepatitis C Investigation Team. A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015. EBioMedicine 2018;37:374-81. [PMID: 30448155 DOI: 10.1016/j.ebiom.2018.10.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
59 Young AM, DiClemente RJ, Halgin DS, Sterk CE, Havens JR. Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis. AIDS Behav 2014;18:1753-63. [PMID: 24849621 DOI: 10.1007/s10461-014-0797-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
60 Hansen ER, Carvalho S, McDonald M, Havens JR. A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs. Drug Alcohol Depend 2021;229:109145. [PMID: 34763138 DOI: 10.1016/j.drugalcdep.2021.109145] [Reference Citation Analysis]
61 Roy É, Arruda N, Bruneau J, Jutras-Aswad D. Epidemiology of Injection Drug Use: New Trends and Prominent Issues. Can J Psychiatry 2016;61:136-44. [PMID: 27254088 DOI: 10.1177/0706743716632503] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
62 Bolinski R, Ellis K, Zahnd WE, Walters S, McLuckie C, Schneider J, Rodriguez C, Ezell J, Friedman SR, Pho M, Jenkins WD. Social norms associated with nonmedical opioid use in rural communities: a systematic review. Transl Behav Med 2019;9:1224-32. [PMID: 31504988 DOI: 10.1093/tbm/ibz129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
63 Verna EC, Schluger A, Brown RS Jr. Opioid epidemic and liver disease. JHEP Rep 2019;1:240-55. [PMID: 32039374 DOI: 10.1016/j.jhepr.2019.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Vickers Smith R, Boland EM, Young AM, Lofwall MR, Quiroz A, Staton M, Havens JR. A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky. Psychol Addict Behav 2018;32:115-21. [PMID: 29239621 DOI: 10.1037/adb0000337] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
65 Havens JR, Schaninger T, Fraser H, Lofwall M, Staton M, Young AM, Hoven A, Walsh SL, Vickerman P. Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C. BMJ Open 2021;11:e041490. [PMID: 34226208 DOI: 10.1136/bmjopen-2020-041490] [Reference Citation Analysis]
66 Fraser H, Vellozzi C, Hoerger TJ, Evans JL, Kral AH, Havens J, Young AM, Stone J, Handanagic S, Hariri S, Barbosa C, Hickman M, Leib A, Martin NK, Nerlander L, Raymond HF, Page K, Zibbell J, Ward JW, Vickerman P. Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison. Am J Epidemiol 2019;188:1539-51. [PMID: 31150044 DOI: 10.1093/aje/kwz097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
67 Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M. Injection drug network characteristics as a predictor of injection behaviour. Epidemiol Infect 2019;147:e173. [PMID: 31063105 DOI: 10.1017/S095026881900061X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Hochstatter KR, Gustafson DH Sr, Landucci G, Pe-Romashko K, Cody O, Maus A, Shah DV, Westergaard RP. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial. JMIR Mhealth Uhealth 2021;9:e23080. [PMID: 33616545 DOI: 10.2196/23080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug Alcohol Depend 2015;151:47-55. [PMID: 25823907 DOI: 10.1016/j.drugalcdep.2015.02.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
70 Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 2018;18:1397-409. [PMID: 30385157 DOI: 10.1016/S1473-3099(18)30469-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 15.8] [Reference Citation Analysis]
71 Dunn KE, Brands B, Marsh DC, Bigelow GE. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study. Psychopharmacology (Berl) 2018;235:971-81. [PMID: 29270641 DOI: 10.1007/s00213-017-4814-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
72 Linn BK, Ely GE, Staton M. Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia. J Soc Work Pract Addict 2020;20:155-67. [PMID: 33209100 DOI: 10.1080/1533256X.2020.1748976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Havens JR, Knudsen HK, Young AM, Lofwall MR, Walsh SL. Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugs. Prev Med 2020;140:106194. [PMID: 32652132 DOI: 10.1016/j.ypmed.2020.106194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Stone J, Fraser H, Young AM, Havens JR, Vickerman P. Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky. Int J Drug Policy 2021;88:102707. [PMID: 32151496 DOI: 10.1016/j.drugpo.2020.102707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Fischer B, Pang M, Jones W. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis? Subst Abuse Treat Prev Policy 2020;15:14. [PMID: 32066470 DOI: 10.1186/s13011-020-0256-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
76 Hofmeister MG, Havens JR, Young AM. Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs. J Prim Prev 2017;38:481-94. [PMID: 28733798 DOI: 10.1007/s10935-017-0483-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
77 Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015;26:1056-1063. [PMID: 26050614 DOI: 10.1016/j.drugpo.2015.04.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
78 Young AM, Stephens DB, Khaleel HA, Havens JR. Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemp Clin Trials. 2015;41:9-16. [PMID: 25553715 DOI: 10.1016/j.cct.2014.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
79 Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs. Addiction 2019;114:2267-78. [PMID: 31307116 DOI: 10.1111/add.14731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
80 Bartholomew TS, Patel H, McCollister K, Feaster DJ, Tookes HE. Implementation and first-year operating costs of an academic medical center-based syringe services program. Harm Reduct J 2021;18:116. [PMID: 34798887 DOI: 10.1186/s12954-021-00563-8] [Reference Citation Analysis]
81 Chen YC, Thio CL, Kamangar F, Cox AL, Wiberg KJ. Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting. J Viral Hepat 2020;27:1202-13. [PMID: 32579777 DOI: 10.1111/jvh.13354] [Reference Citation Analysis]
82 Staton-Tindall M, Harp KLH, Minieri A, Oser C, Webster JM, Havens J, Leukefeld C. An exploratory study of mental health and HIV risk behavior among drug-using rural women in jail. Psychiatr Rehabil J 2015;38:45-54. [PMID: 25799305 DOI: 10.1037/prj0000107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
83 Moody L, Satterwhite E, Bickel WK. Substance Use in Rural Central Appalachia: Current Status and Treatment Considerations. Rural Ment Health 2017;41:123-35. [PMID: 29057030 DOI: 10.1037/rmh0000064] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
84 Smith RV, Lofwall MR, Havens JR. Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky. Am J Psychiatry 2015;172:487-8. [PMID: 25930135 DOI: 10.1176/appi.ajp.2014.14101272] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
85 Valdiserri R, Khalsa J, Dan C, Holmberg S, Zibbell J, Holtzman D, Lubran R, Compton W. Confronting the emerging epidemic of HCV infection among young injection drug users. Am J Public Health 2014;104:816-21. [PMID: 24625174 DOI: 10.2105/AJPH.2013.301812] [Cited by in Crossref: 65] [Cited by in F6Publishing: 36] [Article Influence: 8.1] [Reference Citation Analysis]
86 Strickland JC, Staton M, Leukefeld CG, Oser CB, Webster JM. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system. Int J Prison Health 2018;14:89-100. [PMID: 29869584 DOI: 10.1108/IJPH-03-2017-0012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]